Author:
Gassmann Oliver,Schuhmacher Alexander,von Zedtwitz Max,Reepmeyer Gerrit
Publisher
Springer International Publishing
Reference38 articles.
1. Agrafiotis, D. K., Alex, S., Dai, H., Derkinderen, A., Farnum, M., Gates, P., et al. (2007). Advanced biological and chemical discovery (ABCD): Centralizing discovery knowledge in an inherently decentralized world. Journal of Chemical Informatics and Modeling, 47, 1999–2014.
2. Agrafiotis, D. K., Lobanov, V. S., & Salemme, F. R. (2002). Combinatorial informatics in the post-genomics era. Nature Reviews Drug Discovery, 1, 337–346.
3. Baumann, G. (2003). The challenge of innovation in the drug discovery process. Presentation at CTO-Roundtable ‘Management of Pharmaceutical R&D in Turbulent Times – Perspectives and Trends’. Zurich 2003.
4. Beckman, R. A., Clark, J., & Chen, C. (2011). Integrating predictive biomarkers and classifiers into oncology clinical development programmes. Nature Reviews Drug Discovery, 10, 735–748.
5. Bleicher, K. H., Böhm, H. J., Müller, K., & Alanine, A. I. (2003). A guide to drug discovery: Hit and lead generation: Beyond high-throughput screening. Nature Reviews Drug Discovery, 2, 369–378.